NCT05864144 2025-08-15A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid TumorsSensei Biotherapeutics, Inc.Phase 1/2 Active not recruiting98 enrolled
NCT03367819 2022-05-16Isatuximab in Combination With REGN2810 (Cemiplimab) in Patients With Advanced MalignanciesSanofiPhase 1/2 Terminated44 enrolled 24 charts